BeiGene Shares Rise After Q2 Revenue More Than Doubles Y/Y
U.S.-listed shares of BeiGene rose as much as 3% to $174.72 in Thursday morning trading, after the
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial